4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-014088
President sold 30,000 shares at an average $57.58 ($1,727,410)
- President acquired 30,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
RUBINSTEIN JULIE · President
Table I: Non-derivative
9 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-22 | Exercise or conversion : show line 1 in the form | +15,000 | $6.55 | $98,250 | 15,000 | D |
| 2021-02-22 | Sale : show line 2 in the form | −9,844 | $59.28 | $583,552 | 5,156 | D |
| 2021-02-22 | Sale : show line 3 in the form | −4,100 | $60.21 | $246,861 | 1,056 | D |
| 2021-02-22 | Sale : show line 4 in the form | −400 | $61.01 | $24,404 | 656 | D |
| 2021-02-22 | Sale : show line 5 in the form | −656 | $62.20 | $40,803 | 0 | D |
| 2021-02-23 | Exercise or conversion : show line 6 in the form | +15,000 | $6.55 | $98,250 | 15,000 | D |
| 2021-02-23 | Sale : show line 7 in the form | −3,500 | $54.16 | $189,560 | 11,500 | D |
| 2021-02-23 | Sale : show line 8 in the form | −4,461 | $55.54 | $247,764 | 7,039 | D |
| 2021-02-23 | Sale : show line 9 in the form | −7,039 | $56.04 | $394,466 | 0 | D |
| Open-market sales · 30,000 sh · avg $57.58 · $1,727,410 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-02-22 | Exercise or conversion : show line 10 in the form Stock Option (Right to Buy) | −15,000 | 270,000 | D |
| 2021-02-23 | Exercise or conversion : show line 11 in the form Stock Option (Right to Buy) | −15,000 | 255,000 | D |
Loading xslF345X03/doc4.xml…